The Option Value of Innovation
Forum for Health Economics & Policy · 2012
DOI: 10.1515/1558-9544.1306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Forum for Health Economics & Policy, 2012. Verfasst von Julia Thornton Snider und 3 weiteren Autor:innen. Beteiligte Einrichtung: Precision Health Economics,julia@precisionhealtheconomics.com. Die Arbeit wurde bisher 10-mal zitiert (Crossref).
Abstract (Originalsprache)
Standard techniques of cost effectiveness analysis measure a technology’s benefits in terms of expected life years (or quality-adjusted life years) gained at today’s life expectancies. However, this approach ignores the gains which derive from the possibility that a health technology allows an individual to survive long enough to benefit from other technological innovations which raise life expectancy (and quality of life) in the future. Borrowing a term from the finance literature, we refer to this source of value as the “option value” of innovation. We explain where this value comes from and how to calculate it in a variety of standard cost effectiveness analysis contexts. We provide a proof-of-concept using the example of the drug tamoxifen, which delayed the onset of breast cancer for some patients until more effective adjuvant treatment was available. We find that incorporating option value can increase the conventionally estimated value of tamoxifen with better adjuvant treatment by nearly a quarter (from $200,000 to $248,000 for those who initiated tamoxifen in 1999). We expect similar results for other drugs in therapeutic areas of rapid technological advancement.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Precision Health Economics,julia@precisionhealtheconomics.com.
- University of Southern California,romley@healthpolicy.usc.edu.
- University of Georgia,wbvogt@uga.edu.
- University of Chicago,t-philipson@uchicago.edu.
Zitieren
APA
Thornton Snider, J., Romley, J. A., Vogt, W. B., & Philipson, T. J. (2012). The Option Value of Innovation. Forum for Health Economics & Policy. https://doi.org/10.1515/1558-9544.1306
Vancouver
Thornton Snider J, Romley JA, Vogt WB, Philipson TJ. The Option Value of Innovation. Forum for Health Economics & Policy. 2012. doi:10.1515/1558-9544.1306
BibTeX
@article{ThorntonSnider2012,
author = {Thornton Snider, Julia and Romley, John A and Vogt, William B and Philipson, Tomas J},
title = {The Option Value of Innovation},
journal = {Forum for Health Economics & Policy},
year = {2012},
doi = {10.1515/1558-9544.1306}
}
EUVIMED